Processa Pharmaceuticals's total assets for Q4 2024 were $3.23M, a decrease of -34.66% from the previous quarter. PCSA total liabilities were $1.53M for the fiscal quarter, a 25.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.